ASDAS Is More Important Than BASDAI in Advanced Ankylosing Spondylitis - ACR Meeting Abstracts

Background/Purpose: In patients with ankylosing spondylitis, the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is used to measure disease activity to initiate or maintain TNF inhibitor therapy. However, despite a low disease activity measured by BASDAI, some patients complain of pain or are found in high inflammatory status. In such cases, other disease activity measurement […]

Safety Profile, Axial Spondyloarthritis

Ixekizumab Significantly Improves Signs, Symptoms, and Spinal Inflammation of Active Ankylosing Spondylitis/Radiographic Axial Spondyloarthritis: 16-Week Results of a Phase 3 Randomized, Active and Placebo-Controlled Trial - ACR Meeting Abstracts

Nonbiologic Therapy, Ankylosing Spondylitis

Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

Which Disease Activity Outcome Measure Discriminates Best in Axial Spondyloarthritis? A Systematic Literature Review and Meta-analysis - ACR Meeting Abstracts

PDF) The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

The Bath Ankylosing Spondylitis Functional Index's History & Patient View - The Rheumatologist

Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

Characterization of Non-radiographic Axial Spondyloarthritis Patients and the Burden of Disease in Routine Clinical Practice - ACR Meeting Abstracts

Ankylosing spondylitis: etiology, pathogenesis, and treatments